TempraMed schliesst Vertriebsvereinbarung mit Humana-Tochter CenterWell Pharmacy

Von Public Technologies
  • TempraMed Technologies schliesst Distributionsvereinbarung mit CenterWell Pharmacy, der Pharmacy-Services-Marke von Humana.
  • Vertrag datiert vom 25. August 2026.
  • Kooperation soll den Vertrieb von TempraMeds temperaturkontrollierten Medikamenten-Storage-Lösungen über CenterWell stärken.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609230305NEWSFILECNPR____20260923_315436_1) on September 23, 2026, and is solely responsible for the information contained therein.